Beyond individual case reports, case series on SLE, IIM, and SC (20), as well as a Phase I clinical trial summarizing the use of BCMA-CD19 CAR-T cell therapy for SLE (16), have also been published. Here, CD19 is linked to systemic lupus erythematosus.